Author

Perianne Smith

Memorial Sloan Kettering Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Assay:organoid / primary culture· 1

Frequent Co-Authors

Charles L. SawyersiD· 2 shared Agnieszka ChryplewicziD· 1 shared Anuradha GopalaniD· 1 shared Brett Stewart CarveriD· 1 shared Dana Pe’eriD· 1 shared Elisa de StanchinaiD· 1 shared Emmet Huang-HobbsiD· 1 shared Eric Huttenlocher BentiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Charles L. SawyersORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

IL-1β/IL-6 signaling circuit in the tumor microenvironment drives prostate cancer development

Young Sun Lee, Jimmy L. Zhao, Agnieszka Chryplewicz, Max Land, Roshan Sharma, Joseph Chan, Perianne Smith, Sanjay V. Kottapalli, Linda E. Fong, Zhenghao Chen, Eric Huttenlocher Bent, HuiYong Zhao, Elisa de Stanchina, Wenfei Kang, Shevin Narine, , Charles L. Sawyers

This study identifies an IL-1β/IL-6 signaling circuit in the tumor microenvironment that drives prostate cancer progression from pre-invasive to invasive stages.

bioRxiv · Jul 31, 2026 · PreprintCancer Biology

BRCA2 reversion mutation-independent resistance to PARP inhibition in prostate cancer through loss of function perturbations in the DNA pre-replication complex

Kyrie Pappas, Matteo Ferrari, Perianne Smith, Subhiksha Nandakumar, Zahra Khan, Serina B Young, Justin R. LaClair, Marco Vincenzo Russo, Emmet Huang-Hobbs, Nikolaus D. Schultz, Wassim M. Abida, Wouter R. Karthaus, Maria Jasin, Charles L. Sawyers

This study identifies loss of function mutations in the DNA pre-replication complex as a mechanism for PARP inhibitor resistance in BRCA-mutant prostate cancer, independent of reversion mutations.

bioRxiv · Apr 20, 2025 · PreprintCancer Biology